Albion Financial Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3K | Sell |
248
-360
| -59% | -$25.2K | ﹤0.01% | 322 |
|
|
2025
Q1 | $44.7K | Hold |
608
| – | – | ﹤0.01% | 251 |
|
|
2024
Q4 | $39.8K | Buy |
608
+248
| +69% | +$16.2K | ﹤0.01% | 269 |
|
|
2024
Q3 | $28K | Hold |
360
| – | – | ﹤0.01% | 266 |
|
|
2024
Q2 | $28.1K | Hold |
360
| – | – | ﹤0.01% | 268 |
|
|
2024
Q1 | $24.4K | Hold |
360
| – | – | ﹤0.01% | 266 |
|
|
2023
Q4 | $24.2K | Hold |
360
| – | – | ﹤0.01% | 257 |
|
|
2023
Q3 | $24.4K | Hold |
360
| – | – | ﹤0.01% | 250 |
|
|
2023
Q2 | $25.8K | Hold |
360
| – | – | ﹤0.01% | 256 |
|
|
2023
Q1 | $25K | Hold |
360
| – | – | ﹤0.01% | 247 |
|
|
2022
Q4 | $24.4K | Hold |
360
| – | – | ﹤0.01% | 245 |
|
|
2022
Q3 | $20K | Sell |
360
-52
| -13% | -$2.89K | ﹤0.01% | 258 |
|
|
2022
Q2 | $27K | Hold |
412
| – | – | ﹤0.01% | 249 |
|
|
2022
Q1 | $27K | Sell |
412
-52
| -11% | -$3.41K | ﹤0.01% | 291 |
|
|
2021
Q4 | $27K | Buy |
464
+78
| +20% | +$4.54K | ﹤0.01% | 331 |
|
|
2021
Q3 | $23K | Hold |
386
| – | – | ﹤0.01% | 313 |
|
|
2021
Q2 | $23K | Buy |
+386
| New | +$23K | ﹤0.01% | 318 |
|
|
2020
Q4 | $20K | Buy |
+396
| New | +$20K | ﹤0.01% | 308 |
|
|
2014
Q2 | – | Sell |
-13,240
| Closed | -$430K | – | 192 |
|
|
2014
Q1 | $430K | Buy |
13,240
+450
| +4% | +$14.6K | 0.08% | 121 |
|
|
2013
Q4 | $380K | Buy |
12,790
+3,560
| +39% | +$106K | 0.07% | 121 |
|
|
2013
Q3 | $240K | Buy |
+9,230
| New | +$240K | 0.05% | 143 |
|